Gene · 8405
Papers2,215
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 2,215
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| TMEM160 promotes tumor immune evasion and radiotherapy resistance via PD-L1 binding in colorectal cancer. | Cell Commun Signal | 2024 | 38454413 | PubTator, text mining | PubMed |
| SPOP point mutations regulate substrate preference and affect its function. | Cell Death Dis | 2024 | 38409107 | PubTator, text mining | PubMed |
| Synthesis and Biological Evaluation of β-Lactam Derivatives Targeting Speckle-Type POZ Protein (SPOP). | ACS Med Chem Lett | 2024 | 38352842 | PubTator, text mining | PubMed |
| Comparative study on measurements of radiochromic films using portable colorimeters. | Sci Rep | 2024 | 38336983 | PubTator, text mining | PubMed |
| CSN6-SPOP-HMGCS1 Axis Promotes Hepatocellular Carcinoma Progression via YAP1 Activation. | Adv Sci (Weinh) | 2024 | 38308184 | PubTator, text mining | PubMed |
| Identification and validation of an individualized metabolic prognostic signature for predicting the biochemical recurrence of prostate cancer based on the immune microenvironment. | Eur J Med Res | 2024 | 38297388 | PubTator, text mining | PubMed |
| Regulating Androgen Receptor Function in Prostate Cancer: Exploring the Diversity of Post-Translational Modifications. | Cells | 2024 | 38275816 | PubTator, text mining | PubMed |
| Organoids: An Emerging Precision Medicine Model for Prostate Cancer Research. | Int J Mol Sci | 2024 | 38256166 | PubTator, text mining | PubMed |
| Mismatch Repair Deficiency as a Predictive and Prognostic Biomarker in Endometrial Cancer: A Review on Immunohistochemistry Staining Patterns and Clinical Implications. | Int J Mol Sci | 2024 | 38256131 | PubTator, text mining | PubMed |
| Integrated analysis of single-cell and bulk transcriptomics develops a robust neuroendocrine cell-intrinsic signature to predict prostate cancer progression. | Theranostics | 2024 | 38250042 | PubTator, text mining | PubMed |
| Targeted Protein Degradation Systems: Controlling Protein Stability Using E3 Ubiquitin Ligases in Eukaryotic Species. | Cells | 2024 | 38247866 | PubTator, text mining | PubMed |
| The Multifaceted Roles of NRF2 in Cancer: Friend or Foe? | Antioxidants (Basel) | 2024 | 38247494 | PubTator, text mining | PubMed |
| Deficiency in SPOP-mediated ubiquitination and degradation of TIAM1 promotes gastric cancer progression. | Biochim Biophys Acta Mol Basis Dis | 2024 | 38246227 | PubTator, text mining | PubMed |
| SPOP negatively regulates mTORC1 activity by ubiquitinating Sec13. | Cell Signal | 2024 | 38242269 | PubTator, text mining | PubMed |
| Phosphorylation of INF2 by AMPK promotes mitochondrial fission and oncogenic function in endometrial cancer. | Cell Death Dis | 2024 | 38233384 | PubTator, text mining | PubMed |
| An endoplasmic reticulum stress-related signature featuring ASNS for predicting prognosis and immune landscape in prostate cancer. | Aging (Albany NY) | 2024 | 38206293 | PubTator, text mining | PubMed |
| Therapeutic Approaches to Targeting Androgen Receptor Splice Variants. | Cells | 2024 | 38201308 | PubTator, text mining | PubMed |
| Natural products targeting the MAPK-signaling pathway in cancer: overview. | J Cancer Res Clin Oncol | 2024 | 38193944 | PubTator, text mining | PubMed |
| A carboxy-terminal ubiquitylation site regulates androgen receptor activity. | Commun Biol | 2024 | 38182874 | PubTator, text mining | PubMed |
| Tumor microenvironment deconvolution identifies cell-type-independent aberrant DNA methylation and gene expression in prostate cancer. | Clin Epigenetics | 2024 | 38173042 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8405/papers?page=10